Cao, X., Orlowski, R. Z., Qazilbash, M., Liu, Z., Xu-Monette, Z. Y., Medeiros, L. J., & Young, K. H. (2015). Extramedullary involvement at diagnosis is a poor prognostic factor in patients with Waldenstrom macroglobulinemia: The MD Anderson Cancer Center experience. In Clinical Lymphoma Myeloma and Leukemia (Vol. 15, pp. S229–S229). Elsevier BV. https://doi.org/10.1016/j.clml.2015.04.110

Cao, Xin, Robert Z. Orlowski, Muzaffar Qazilbash, Zhiyu Liu, Zijun Y. Xu-Monette, L Jeffrey Medeiros, and Ken H. Young. “Extramedullary involvement at diagnosis is a poor prognostic factor in patients with Waldenstrom macroglobulinemia: The MD Anderson Cancer Center experience.” In Clinical Lymphoma Myeloma and Leukemia, 15:S229–S229. Elsevier BV, 2015. https://doi.org/10.1016/j.clml.2015.04.110.

Cao X, Orlowski RZ, Qazilbash M, Liu Z, Xu-Monette ZY, Medeiros LJ, et al. Extramedullary involvement at diagnosis is a poor prognostic factor in patients with Waldenstrom macroglobulinemia: The MD Anderson Cancer Center experience. In: Clinical Lymphoma Myeloma and Leukemia. Elsevier BV; 2015. p. S229–S229.

Cao, Xin, et al. “Extramedullary involvement at diagnosis is a poor prognostic factor in patients with Waldenstrom macroglobulinemia: The MD Anderson Cancer Center experience.” Clinical Lymphoma Myeloma and Leukemia, vol. 15, Elsevier BV, 2015, pp. S229–S229. Crossref, doi:10.1016/j.clml.2015.04.110.

Cao X, Orlowski RZ, Qazilbash M, Liu Z, Xu-Monette ZY, Medeiros LJ, Young KH. Extramedullary involvement at diagnosis is a poor prognostic factor in patients with Waldenstrom macroglobulinemia: The MD Anderson Cancer Center experience. Clinical Lymphoma Myeloma and Leukemia. Elsevier BV; 2015. p. S229–S229.